장골 스텐트 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Iliac Stent Market size is expected to reach USD 1.64 Billion in 2034 from USD 1.01 Billion (2025) growing at a CAGR of 5.51% during 2026-2034.

The Global Iliac Stent Market is witnessing steady growth due to the rising prevalence of peripheral artery disease (PAD) and increasing cases of lifestyle-related vascular disorders. Aging populations, especially in developed nations, are contributing significantly to the demand for minimally invasive vascular interventions. Technological advancements in self-expanding and drug-eluting stents have improved procedural success rates and reduced complications, further accelerating market adoption.

Key growth drivers include the increasing number of endovascular procedures, growing awareness about early diagnosis of arterial blockages, and expanding healthcare infrastructure in emerging economies. Physicians are increasingly preferring stenting procedures over open surgeries due to shorter hospital stays and faster recovery times. Favorable reimbursement policies in developed countries also support market expansion.

Looking ahead, the market is expected to benefit from ongoing innovation in bioresorbable stents and advanced imaging-guided procedures. Rising investments in cardiovascular research and the integration of AI in vascular diagnostics may further enhance procedural accuracy. Emerging markets in Asia-Pacific and Latin America are projected to offer lucrative opportunities due to improving access to advanced medical devices.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Self-Expandable Stents
• Balloon-Expandable Stents
• Covered Stents

By Artery Lesions

• Common Iliac Artery Lesions
• Severe Calcified Lesions
• Complete Obstructive Lesions

By End-Use

• Hospitals
• Ambulatory Surgical Centers
• Other

COMPANIES PROFILED

• Abbott Laboratories, Alvimedica, Becton, Dickinson and Company, Biotronik, Boston Scientific Corporation, B Braun SE, Cook, Getinge AB, iVascular, Medtronic Plc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ILIAC STENT MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Self-Expandable Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Balloon-Expandable Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Covered Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ILIAC STENT MARKET: BY ARTERY LESIONS 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Artery Lesions
• 5.2. Common Iliac Artery Lesions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Severe Calcified Lesions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Complete Obstructive Lesions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ILIAC STENT MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ILIAC STENT MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Artery Lesions
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Artery Lesions
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Artery Lesions
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Artery Lesions
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Artery Lesions
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ILIAC STENT INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott Laboratories
  • 9.2.2 Alvimedica
  • 9.2.3 Becton
  • 9.2.4 Dickinson And Company
  • 9.2.5 Biotronik
  • 9.2.6 Boston Scientific Corporation
  • 9.2.7 B. Braun SE
  • 9.2.8 Cook
  • 9.2.9 Getinge AB
  • 9.2.10 IVascular
  • 9.2.11 Medtronic Plc